Загрузка...
Managing the competing risks of thrombosis, bleeding, and anticoagulation in patients with malignancy
The association between malignancy and thrombosis has been recognized for over a century and a half. Patients with cancer have an elevated risk of both initial and recurrent venous thromboembolism (VTE) compared with patients without cancer owing to cancer- and patient-specific factors. Recurrent VT...
Сохранить в:
| Опубликовано в: : | Hematology Am Soc Hematol Educ Program |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
American Society of Hematology
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6913483/ https://ncbi.nlm.nih.gov/pubmed/31808892 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/hematology.2019000369 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|